KalVista Pharmaceuticals ... (KALV)
NASDAQ: KALV
· Real-Time Price · USD
12.89
-0.06 (-0.46%)
At close: Aug 15, 2025, 3:59 PM
13.13
1.82%
After-hours: Aug 15, 2025, 07:39 PM EDT
KalVista Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Net Income | -183.44M | -175.87M | -156.39M | -141.77M | -126.64M | -108.3M | -100.58M | -95.18M | -92.91M | -90.72M | -91.88M | -89.27M | -82.34M | -73.18M | -60.76M | -51.54M | -46.24M | -37.87M | -37.12M | -32.59M |
Depreciation & Amortization | 955K | 899K | 877K | 847K | 816K | 785K | 777K | 753K | 718K | 686K | 636K | 590K | 564K | 548K | 535K | 541K | 537K | 109K | 252K | 381K |
Stock-Based Compensation | n/a | 21.39M | 21.49M | 21.7M | 21.91M | 11.61M | 11.23M | 10.53M | 9.92M | 10.13M | 10.58M | 10.93M | 11.09M | 11.87M | 10.34M | 8.72M | 7.12M | 4.77M | 4.65M | 4.56M |
Other Working Capital | 23.63M | 2.36M | 3.72M | 330K | 2.78M | 4.78M | 13.45M | 8.88M | 8.98M | 2.27M | -4.38M | -9.17M | -14.01M | -6.85M | -8.95M | -2.94M | 8.2M | 3.63M | -5.03M | -7.21M |
Other Non-Cash Items | 7.3M | 5.82M | 5.17M | 5.96M | 6.16M | 6.22M | -899K | -1.67M | -1.11M | 503K | 989K | 1.8M | 1.8M | 242K | 143K | 128K | 114K | 322K | 128K | -472K |
Deferred Income Tax | n/a | n/a | -7.17M | -6.54M | -6.65M | -6.77M | 398K | -234K | -126K | n/a | 1.26M | 2.29M | 3.08M | 3.42M | 1.92M | 1.18M | -42K | -386K | -147K | -434K |
Change in Working Capital | 22.28M | 20.11M | 13.48M | 17.08M | 15.17M | -309K | 10.58M | 6.55M | 7.41M | -856K | -6.61M | -10.31M | -12.32M | -5.29M | -8.08M | -3.35M | 8.35M | 1.32M | -5.03M | -8.57M |
Operating Cash Flow | -152.91M | -127.65M | -122.54M | -102.72M | -89.23M | -96.76M | -78.48M | -79.25M | -75.26M | -79.41M | -84.19M | -83.14M | -78.13M | -62.39M | -55.91M | -44.32M | -30.17M | -31.74M | -37.27M | -37.13M |
Capital Expenditures | n/a | -766K | -658K | -661K | -646K | -299K | -295K | -282K | -1.2M | -1.21M | -1.4M | -1.56M | -931K | -878K | -690K | -347K | -82K | -57K | -43K | -144K |
Cash Acquisitions | 434K | 105K | 105K | 308K | n/a | -1.04M | -1.04M | -1.24M | -933.5K | -57.86M | -57.86M | -57.86M | -57.55M | 147.96M | 147.96M | 147.96M | 147.61M | -16.8M | -16.8M | -16.8M |
Purchase of Investments | 30.57M | -149.09M | -160.68M | -164.45M | -189.23M | -82.18M | -117.68M | -113.91M | -98.25M | -116.26M | -95.33M | -127.99M | -136.92M | -258.81M | -233.56M | -210.44M | -201.21M | -31.5M | -26.58M | -39.96M |
Sales Maturities Of Investments | 122.52M | 116.83M | 113.18M | 97.8M | 104.95M | 117.82M | 157.42M | 145.18M | 140.86M | 177.53M | 172.21M | 202.57M | 195.71M | 138.63M | 107.24M | 72.5M | 53.64M | 60.41M | 58.3M | 63.9M |
Other Investing Acitivies | -62.51M | 870K | 882K | -64K | 308K | 950K | 1.04M | 1.26M | 984.75K | 57.91M | 57.92M | 57.92M | 57.58M | -147.93M | -147.94M | -147.95M | -147.59M | 16.81M | 16.82M | 16.81M |
Investing Cash Flow | 91.02M | -31.83M | -47.05M | -67.17M | -84.72M | 35.26M | 39.44M | 30.98M | 41.41M | 60.06M | 75.48M | 73.02M | 57.86M | -121.06M | -127.01M | -138.29M | -147.65M | 28.86M | 31.68M | 23.8M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -333 | -333 | -333 | -333 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 98.04M | 148.38M | 53.44M | 53.56M | 53.77M | 616K | 58.15M | 58.19M | 58.15M | 58.29M | 1.25M | 1.14M | 1.58M | 2.82M | 2.1M | 2.1M | 1.53M | 163K | 152K | 230K |
Financial Cash Flow | 159.73M | 305.17M | 153.68M | 153.51M | 150.71M | 583K | 58.11M | 58.15M | 58.12M | 58.29M | 1.25M | 1.14M | 1.58M | 211.75M | 212.68M | 212.68M | 212.12M | 1.81M | 152K | 230K |
Net Cash Flow | 100.48M | 144.88M | -16.09M | -17.56M | -24.45M | -61.99M | 19.08M | 11.55M | 25.51M | 39.47M | -7.91M | -10.48M | -19.86M | 27.85M | 30.32M | 30.33M | 34.8M | -888K | -5.54M | -12.09M |
Free Cash Flow | -152.91M | -128.41M | -123.2M | -103.38M | -89.88M | -97.06M | -78.78M | -79.53M | -76.46M | -80.63M | -85.59M | -84.7M | -79.06M | -63.27M | -56.6M | -44.66M | -30.25M | -31.8M | -37.31M | -37.27M |